Advertisement

Topics

T-cellic A/S Company Profile

09:46 EST 16th December 2018 | BioPortfolio

T-cellic’s foundation is an epoch-making discovery in the use of the immune system’s T-cells for providing effective treatment of cancer. T-cell-guided therapy, discovered in November 1999 by the world’s leading professor in stereology, H. J. Gundersen, has awakened substantial interest from all over the world. And has drawn highly experienced people from the pharmaceutical industry to join T-cellic.

Location

Agern Allé 7
Hørsholm
DK-2970
Denmark

Contact

Phone: (45) 72 100 610
Fax: (45) 45 54 16 10
Email: info@t-cellic.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Integrated production of cellulosic bioethanol and succinic acid from rapeseed straw after dilute-acid pretreatment.

The aim of this study was to develop an integrated biofuel (cellulosic bioethanol) and biochemical (succinic acid) production process from rapeseed straw after dilute-acid pretreatment. Rapeseed straw...

Extraction, characterization and immunomodulatory property of pectic polysaccharide from pomegranate peels: Enzymatic vs conventional approach.

Molecular characteristics, structural properties and immunostimulatory activities of polysaccharides from pomegranate peel were evaluated after 0.1 M HCl, Cellic CTec2 and buffer extractions. The is...

Evaluating novel fungal secretomes for efficient saccharification and fermentation of composite sugars derived from hydrolysate and molasses into ethanol.

This paper evaluates the ability of secretome from two thermotolerant fungal strains (Aspergillus terreus 9DR and Achaetomium strumarium 10DR) for boosting the hydrolytic efficiency of benchmark cellu...

Purification and characterization of a novel GH1 beta-glucosidase from Jeotgalibacillus malaysiensis.

Beta-glucosidase (BGL) is an important industrial enzyme for food, waste and biofuel processing. Jeotgalibacillus is an understudied halophilic genus, and no beta-glucosidase from this genus has been ...

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

T-cellic A/S

T-cellic’s foundation is an epoch-making discovery in the use of the immune system’s T-cells for providing effective treatment of cancer. T-cell-guided therapy, discovered in November 1999 by the ...

More Information about "T-cellic A/S" on BioPortfolio

We have published hundreds of T-cellic A/S news stories on BioPortfolio along with dozens of T-cellic A/S Clinical Trials and PubMed Articles about T-cellic A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of T-cellic A/S Companies in our database. You can also find out about relevant T-cellic A/S Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record